期刊文献+

Tim-3在宫颈癌组织中的表达及其与恶性进展的关系 被引量:8

Relation of Tim-3 Expression in Cervical Cancer to Tumor Progression
在线阅读 下载PDF
导出
摘要 目的探讨宫颈癌细胞表达T-cell immunoglobulin and mucin domain containing 3 protein(Tim-3)与宫颈癌恶性进展的关系。方法用反转录PCR(RT-PCR)、Western blot和共聚焦显微镜检测宫颈癌细胞系HeLa和SiHa中Tim-3基因和蛋白的表达及其胞内定位;用免疫组织化学法检测43例宫颈癌组织中Tim-3的表达,并分析其与临床分期、组织分型、转移等相关性。结果证实HeLa和SiHa两个宫颈癌细胞系均表达Tim-3,在前者Tim-3分布于胞质,而在后者则分布于核内及其周围。在宫颈癌患者病理标本中可见癌巢和肿瘤血管高表达Tim-3,且Tim-3表达强度与与临床分期、组织分型和转移相关。结论宫颈癌细胞及血管内皮细胞均高表达Tim-3,且Tim-3表达强度与宫颈癌恶性进展及转移高度相关。 Objective To confirm the relationship between Tim-3(T-cell immunoglobulin and mucin domain containing 3 protein) expression in cervical cancer and the progression of the tumor.Methods RT-PCR,Western blot and confocal microscopy were used to detect the expression of Tim-3 in cervical cancer cell lines,HeLa and SiHa,at both gene and protein levels and its intracellular distribution.Meanwhile,specimens from 43 patients with cervical cancer were detected the expression of Tim-3 by immunohistochemistry.We analysed the relation of Tim-3 expression to clinical stage,tissue typing,metastasis.Results Tim-3 was expressed highly in the HeLa and SiHa cells.Moreover,according to the statistics results,Tim-3 expressed highly in the cancer cell,relative to the increased degree of malignancy of cervical cancer.Conclusion Tim-3 is expressed highly in cervical cancer cell and vessel endothelial cell,moreover it is relative to the increased degree of malignancy of cervical cancer.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2012年第11期1353-1356,共4页 Cancer Research on Prevention and Treatment
基金 国家自然科学基金青年科学基金资助项目(81001049)
关键词 宫颈癌 TIM-3 肿瘤临床分期 组织分型 肿瘤转移 Cervical cancer Tim-3 Clinical stage Histological type Tumor metastasis
作者简介 周晓曦(1984-),女,博士在读,主要从事肿瘤免疫方面的研究 通信作者:曹阳E-mail:caoyangemma@163.com
  • 相关文献

参考文献9

  • 1赵方辉,胡尚英,张思维,陈万青,乔友林.2004—2005年中国居民子宫颈癌死亡情况及30年变化趋势[J].中华预防医学杂志,2010,44(5):408-412. 被引量:69
  • 2No JH,Kim MK,Jeon YT,et al. Human papillomavirus vaccine: widening the scope for cancer prevention [J]. Mol Carcinog,2011 ,50(4): 244-53.
  • 3Ibrahim R, Frederickson H, Parr A, et al. Expression of FasL in squamous cell carcinomas of the cervix and cervical intraepithelial neoplasia and its role in tumor escape mechanism[J]. Cancer,2006,106(5): 1065-77.
  • 4Kloth IN,Gorter A, Fleuren GJ,et al. Elevated expression of SerpinAl and SerpinA3 in HLA-positive cervical carcinoma [J]. J PathoI,2008,21S(3): 222-30.
  • 5Hafler DA, Kuchroo V. TIMs: central regulators of immune responses [J]. J Exp Med,2008,20S(12): 2699-701.
  • 6Sakuishi Kv Apetoh L,Sullivan JM,et al. Targeting Tim-3 and PD-l pathways to reverse T cell exhaustion and restore antitumorimmunity[J]. J Exp Med,2010,207(10): 2187-94.
  • 7Fourcade J ,Sun Z,Benallaoua M,et al. Upregulation of Tim-3 and PD-l expression is associated with tumor antigen-specificCD8 + T cell dysfunction in melanoma patients [J]. J Exp Med,2010,207(10): 217S-86.
  • 8Klibi J, Niki T, Riedel A, et al. Blood diffusion and Th l-suppressive effects of galectin-9-containing exosomesreleased by Epstein-Barr virus-infected nasopharyngeal carcinoma cells[J]. Blood,2009 ,113(9): 19S7-66.
  • 9Huang X, Bai X, Cao y, et al. Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progressionof lymphoma by mediating immune evasion[J]. J Exp Med,2010 ,207 (3): 50S-20.

二级参考文献12

  • 1李连弟,鲁凤珠.1990—1992年中国恶性肿瘤死亡流行分布情况分析[J].中华肿瘤杂志,1996,18(6):403-407. 被引量:227
  • 2李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 3Qiao YL,SeUors JW,Eder PS,et al.A new HPV-DNA test for cervical-cancer screening in developing regions:a cross-sectional study of clinical accuracy in rural China.Lancet Oncol,2008,9:929-936.
  • 4Schiffman M,Solomon D.Screening and prevention methods for cervical cancer.JAMA,2009,302:1809-1810.
  • 5Sonkaranarayanan R,Thara S,Esmy PO,et al.Cervical cancer:screening and therapeutic perspectives.Med Princ Pract,2008,17:351-364.
  • 6WorldHealthOrganization.WHOpositiononHPV vaccines.Vaccine,2009,27:7236-7237.
  • 7全国肿瘤防治研究办公室.中国恶件肿瘤死亡调查研究 (1990-1992).北京:人民卫生出版社,2008.
  • 8陈竺.会国第三次死因回顾抽样调查报告.北京:中国协和医科大学出版社,2008:10.
  • 9Parkin DM,Bray F,Feday J,et al.Global cancer statistics,2002.CA Cancer J Cin,2005,55:74-108.
  • 10卫生部全国肿瘤防治研究办公室.中国恶性肿瘤死亡调查研究[M].北京:人民卫生出版社,1980 .

共引文献68

同被引文献67

  • 1Monney L, Sabatos CA, Gaglia JL, et al. Thl-specific cell surface protein TIM-3 regulates macrophage activation and severity of an autoimmune disease[J]. Nature, 2002, 415(6871 ) : 536 -541.
  • 2Sakuishi K, Apetoh L, Sullivan JM, et al. Targeting TIM-3 PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity [J]. J Exp MOd, 2010, 207(10) : 2187 -2194.
  • 3Christian B. The perspective of immunothcrapy: new molecules and new mechanisms of action in immune modulation [ J ]. Curt Opin Oncol, 2014, 26(2) : 204 -214.
  • 4Rdrg C, Ribas A, Wolchok JD, et al. Atti-ptrammed-death-receptor-I with pembrelizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial [J]. Lancet, 2014, 384(9948): 1109-1117.
  • 5Kim PS, Ahmed R. Features of responding T cells in cancer and chronic infection [J]. Curt Opin Immunol, 2010, 22 (2): 223 - 230.
  • 6Nakae S, Iikura M, Suto H, et al. TIM-1 and TIM-3 enhancement of Th2 cytokine production by mast cells[J]. Blood, 2007, 110(7) :2565 -2568.
  • 7Cua DJ, Sherlock J, Chen Y, et aL lmedeukin-23 rather than intedeukin-12 is the critical cytokine for autoimmune inflamnmtion of the brain [ J ]. Nature, 2003, 421(6924): 744-748.
  • 8Anderson AC, Anderson DE, Bregoli L, et al. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on inna: immune cells[J]. Science, 2007, 318(5853) : 1141 -1143.
  • 9Wiener Z, Koh,lml B, Pocza P, et al. TIM-3 is expressed in melanonm cells and is upmgulated in TGF-beta stimulated mast cells [ J ]. J Invest Dermatol, 2007, 127(4) : 906 -914.
  • 10Wang F, He W, Zhou H, et al. The Tim-3 ligand galectin-9 negatively regulates CD8^+ alloreaclive T cell and prolongs survival of skin graft [J]. Cell Immunol, 2007, 250(1/2) : 68 -74.

引证文献8

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部